Motley Fool Premium
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    5 Can’t Miss Investing Stories Last Week

    | Robert Baillieul

    BlackBerry signals a shift to enterprise, Canada's big banks hike their dividends, and is this company the next Johnson &…

    Read more »

    The Motley Fool
    Investing

    This Stock Just Keeps on Rolling

    | Benjamin Sinclair

    But with such a reliance on acquisitions, how long can the good times last?

    Read more »

    The Motley Fool
    Top TSX Stocks

    Top Stock Picks for February

    | Motley Fool Staff

    We asked our contributors to pick their favorite Canadian stocks to buy this month. Here are their top ideas.

    Read more »

    The Motley Fool
    Investing

    2 Amazing Turnarounds, Plus One to Watch

    | Benjamin Sinclair

    Warren Buffett famously avoids turnarounds, but you may want to consider these.

    Read more »

    Investing

    S&P/TSX Flat in Light Trading, Poised to Underperform U.S. by 17%

    | Robert Baillieul

    Money managers were window dressing their portfolios before year-end

    Read more »

    The Motley Fool
    Investing

    S&P/TSX Higher As Investors Await Fed’s Tapering Plans

    | Robert Baillieul

    Disclosure: Robert Baillieul has no positions in any of the stocks mentioned in this article.

    Read more »

    The Motley Fool
    Investing

    5 Barely Profitable Companies Priced to Sell

    | Iain Butler

    Be mindful of relative expectations before wading into this collection of names.

    Read more »

    The Motley Fool
    Investing

    Take Stock – 2013 Year in Review (So Far) and Stocks to Watch for the Second Half

    | Iain Butler

    This week's edition is here! Check it out!

    Read more »

    The Motley Fool
    Investing

    Canadian Stocks Fall, led by Valeant Pharmaceuticals

    | Iain Butler

    The TSX starts the week in the red.

    Read more »

    The Motley Fool
    Investing

    The CFO’s Buying – Are You?

    | Iain Butler

    An academic study indicates there's one insider who's actions mean more than the others.

    Read more »

    The Motley Fool
    Investing

    Canadian Stocks Going for a Memorial Day Run

    | Iain Butler

    Closed U.S. markets haven't stopped these three names from surging higher.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Shares Jump on Rumoured Deal

    | Iain Butler

    This company is going to pull off a massive deal one way or the other.

    Read more »